MurmannWAlmiranteLSaccani-GuelfiM. Effects of hexobarbital, ether, morphine and urethane upon the acute toxicity of propranolol and D-(-)-INPEA. J Pharm Pharmacol1966; 18: 692–4.
2.
WinterJC. Propranolol and morphine: A lethal interaction. Arch Int Pharmacodyn1974; 212: 195–8.
3.
HatoumNSDavisWM. Morphine lethality in rats: Effects of various central receptor blocking agents. Res Commun Chem Pathol Pharmacol1979; 24: 251–7.
4.
DavisWMHatoumNS. Lethal synergism between morphine or other narcotic analgesics and propranolol. Toxicology1979; 14: 141–51.
5.
WinstockMSpeiserZ. The effect of dl-propranolol, d-propranolol and practolol on the hyperactivity induced in rats by prolonged isolation. Psychopharmacologia1977; 30: 241–50.
6.
Executive report 1978: Data from the National Drug Abuse Treatment Utilization Survey. Rockville, MD: National Institute on Drug Abuse, 1978: 6.
7.
AhlquistRP. Propranolol in clinical medicine. Am Heart J. 1979; 97: 137–40.
8.
The top 200 drugs. Pharm Times1980; 46 (3): 1–9.
9.
CluffLEPetricJC, eds. Clinical effects of interaction between drugs. New York: American Elsevier, 1974: 97.
10.
DunphyTW. The pharmacist's role in the prevention of adverse drug interactions. Am J Hosp Pharm1969; 23: 367–77.
11.
GantBRWallerRHMoxnessJN, eds. Drug interaction index, a survey of drug interactions. Kelowna, BC: Meditec Publications, 1971: 53,141.